# Evaluation of Post Hospital Administration of Celecoxib Following Minimally Invasive Knee Replacement Surgery

> **NCT00474773** · — · COMPLETED · sponsor: **St. Louis Joint Replacement Institute** · enrollment: 107 (actual)

## Conditions studied

- Pain Management
- Function
- Minimally Invasive Total Knee Arthroplasty
- Celecoxib

## Interventions

- **DRUG:** Celecoxib

## Key facts

- **NCT ID:** NCT00474773
- **Lead sponsor:** St. Louis Joint Replacement Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2016-04-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00474773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00474773, "Evaluation of Post Hospital Administration of Celecoxib Following Minimally Invasive Knee Replacement Surgery". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT00474773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*